Interferon-Inducible Myxovirus Resistance Proteins: Potential Biomarkers for Differentiating Viral from Bacterial Infections.

Background: In 2015, the 68th World Health Assembly declared that effective, rapid, low-cost diagnostic tools were needed for guiding optimal use of antibiotics in medicine. This review is devoted to interferon-inducible myxovirus resistance proteins as potential biomarkers for differentiating viral from bacterial infections.

Content: After viral infection, a branch of the interferon (IFN)-induced molecular reactions is triggered by the binding of IFNs with their receptors, a process leading to the activation of and , which produce antiviral Mx proteins (MxA and MxB).

Binding of cholera toxin B subunit to intestinal epithelial cells.

We have prepared I-labeled cholera toxin B subunit (I-labeled CT-B, a specific activity of 98Ci/mmol) and found that it binds to rat IEC-6 and human Caco-2 intestinal epithelial cells with high affinity (K 3.6 and 3.7nM, respectively).

Human myeloma IgG4 reveals relatively rigid asymmetric Y-like structure with different conformational stability of C2 domains.

Human IgG4 (hIgG4) has weak pro-inflammatory activity. The structural basis for this is still unclear. Here a 3D model of myeloma hIgG4 was created at ∼3nm resolution using electron microscopy (EM) with negative staining and single-particle 3D reconstruction.

Interaction of Cholera Toxin B-subunit with Human T-lymphocytes.

In this work, I-labeled cholera toxin B-subunit (CT-B) (specific activity 98 Ci/mmol) was prepared, and its high-affinity binding to human blood T-lymphocytes (K = 3.3 nM) was determined. The binding of the I-labeled CT-B was inhibited by unlabeled interferon-α (IFN-α), thymosin-α (TM-α), and by the synthetic peptide LKEKK, which corresponds to sequences 16-20 of human TM-α and 131-135 of IFN-α (K 0.

Interaction of cholera toxin B subunit with T and B lymphocytes.

We have prepared I-labeled cholera toxin B subunit (I-labeled CT-B, a specific activity of 98Ci/mmol) and found that its binding to T and B lymphocytes from the blood of healthy donors was high-affinity (K 2.8 and 3.0nM, respectively).